Skip to main content

Animations

MJFF Publications

7031 - 7040 of 8808 Results
Title
Year
  • Year
  • 2017
  • 2019
  • 2021
  • 2023
  • 2018
  • 2024
  • 2021
  • 2025
  • 2019
  • 2022
  • Summary Details
    RESTRICTED
    Title: Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.016
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-019-1652-8
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
    Journal Name: Genomics, Proteomics & Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathology
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00465-5
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Association study of essential tremor genetic loci in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.01.001
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2024/5580870
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28549
    Citation Count: 98
  • Summary Details
    RESTRICTED
    Title: Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf202
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Parkinson’s progression prediction using machine learning and serum cytokines
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0086-4
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at 16q11.2 and MAPT H1 loci
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac325
    Citation Count: 54
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.